U.S. markets closed
  • S&P Futures

    4,110.50
    -9.00 (-0.22%)
     
  • Dow Futures

    33,618.00
    -64.00 (-0.19%)
     
  • Nasdaq Futures

    13,799.00
    -30.50 (-0.22%)
     
  • Russell 2000 Futures

    2,234.00
    -5.20 (-0.23%)
     
  • Crude Oil

    59.55
    +0.23 (+0.39%)
     
  • Gold

    1,740.10
    -4.70 (-0.27%)
     
  • Silver

    25.20
    -0.12 (-0.47%)
     
  • EUR/USD

    1.1891
    -0.0014 (-0.12%)
     
  • 10-Yr Bond

    1.6660
    +0.0340 (+2.08%)
     
  • Vix

    16.69
    -0.26 (-1.53%)
     
  • GBP/USD

    1.3689
    -0.0016 (-0.12%)
     
  • USD/JPY

    109.5840
    -0.0660 (-0.06%)
     
  • BTC-USD

    60,057.25
    -280.73 (-0.47%)
     
  • CMC Crypto 200

    1,282.68
    +55.14 (+4.49%)
     
  • FTSE 100

    6,915.75
    -26.47 (-0.38%)
     
  • Nikkei 225

    29,761.04
    -7.02 (-0.02%)
     

Recap: InMode Q4 Earnings

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

 

Shares of InMode (NASDAQ:INMD) fell 0.1% in pre-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share increased 104.35% over the past year to $0.94, which beat the estimate of $0.75.

Revenue of $75,187,000 up by 59.97% year over year, which beat the estimate of $70,760,000.

Looking Ahead

Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

How To Listen To The Conference Call

Date: Feb 10, 2021

View more earnings on INMD

Time: 08:30 AM

ET Webcast URL: https://dpregister.com/DiamondPassRegistration/register?confirmationNumber=10151158&linkSecurityString=e064a3345e

Technicals

Company's 52-week high was at $69.91

52-week low: $13.14

Price action over last quarter: Up 64.13%

Company Description

InMode Ltd is a provider of minimally-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions are designed to address three energy-based treatment categories including face and body contouring, medical aesthetics and women's health. The technologies offered by the company include BodyTite, Contoura, EmbraceRF, Optimas, and Votiva among others.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.